Bloodstream Infection (CRBSI/CLABSI)


Active/Enrolling:

Mino-Lok

  • Principal Investigator: Gary Wang, MD, PhD
  • https://clinicaltrials.gov/ct2/show/NCT02901717
  • Hospitalized patients with a catheter-related or central line associated bloodstream infection (CRBSI/CLABSI) typically find that the source of the infection is the lumen of their central venous catheter (CVC). The Mino-Lok study seeks to evaluate the safety and efficacy of Mino-Lok Therapy (MLT) in combination with standard of care antibiotics for treatment of hospitalized patients with CRBSIs and CLABSIs. Patients in this study will be randomized to one of two arms, a MLT arm or a Control Arm receiving antibiotic lock therapy.
  • Contact: Kyle Barbera, kyle.barbera@medicine.ufl.edu, 352-273-8891

Closed to Enrollment:

None at this time; please check back soon.

Pending:

None at this time; please check back soon.

Completed:

None at this time; please check back soon.